More importantly, our study provides a novel RBM15/IGF2BPs/DNMT1 trans-omics regulation m6A axis, indicating the new crosstalk between RNA m6A methylation and DNA methylation in prostate cancer. This evidence concerns the gene RBM15 and prostate carcinoma.